Search Results 1491-1500 of 41591 for oral

  1. Registry of Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Thromboembolic Prevention in Patients with Congenital Heart Disease - Mayo Clinic

    Registry of Efficacy and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Thromboembolic Prevention in Patients with Congenital Heart Disease.

  2. Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia or Lobular Carcinoma In Situ - Mayo Clinic

    The purpose of this study is to analyze breast tissue changes after a short course of Tamoxifen (Tam). Participation eligibility. Participant eligibility ...

  3. Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects with Recurrence of Clostridium difficile Infection - Mayo Clinic

    Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects with Recurrence of Clostridium difficile Infection · More about research at Mayo Clinic.

  4. Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. - Mayo Clinic

    Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. · More about research at Mayo Clinic.

  5. A Study of the Safety, Effectiveness and Maximum Tolerated Dose of Oral PQR309 for Patients with Advanced Solid Tumors - Mayo Clinic

    A Study of the Safety, Effectiveness and Maximum Tolerated Dose of Oral PQR309 for Patients with Advanced Solid Tumors · Share · Facebook · Twitter.

  6. Danicopan (oral route) - Side effects & dosage - Mayo Clinic

    For oral dosage form (tablet):. For extravascular hemolysis (EVH):. Adults—At first, 150 milligrams (mg) 3 times a day. Your doctor may adjust your dose as ...

  7. A Study to Evaluate the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia with Lewy Bodies - Mayo Clinic

    A Study to Evaluate the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia with Lewy Bodies · Overview · Participation eligibility.

  8. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

    The study will evaluate oral daily administration of eFT508. Treatment and study subject evaluation will be performed in 21-day cycles. Participation ...

  9. Levamisole (oral route) - Side effects & dosage - Mayo Clinic

    Levamisole is used with another cancer medicine (fluorouracil) to help make it work better against cancer of the colon. Levamisole is available only with your ...

  10. A Study of Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumors that are Recurrent or Cannot Be Removed by Surgery - Mayo Clinic

    Treatment with oral/systemic corticosteroids, with the exception of topical or inhaled steroids; Current exposure to household contacts ≤ 15 months old or ...